TG Therapeutics, Inc. (TGTX): Price and Financial Metrics
GET POWR RATINGS... FREE!
TGTX POWR Grades
- TGTX scores best on the Growth dimension, with a Growth rank ahead of 74.61% of US stocks.
- The strongest trend for TGTX is in Value, which has been heading down over the past 177 days.
- TGTX ranks lowest in Stability; there it ranks in the 0th percentile.
TGTX Stock Summary
- TG THERAPEUTICS INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 11.09% of US listed stocks.
- TGTX's price/sales ratio is 409.27; that's higher than the P/S ratio of 99.01% of US stocks.
- With a year-over-year growth in debt of 209.85%, TG THERAPEUTICS INC's debt growth rate surpasses 93.2% of about US stocks.
- If you're looking for stocks that are quantitatively similar to TG THERAPEUTICS INC, a group of peers worth examining would be CRBU, RXRX, ADAP, MCRB, and AGLE.
- Visit TGTX's SEC page to see the company's official filings. To visit the company's web site, go to www.tgtherapeutics.com.
TGTX Valuation Summary
- TGTX's EV/EBIT ratio is -7.7; this is 177.78% lower than that of the median Healthcare stock.
- Over the past 155 months, TGTX's price/sales ratio has gone NA NA.
Below are key valuation metrics over time for TGTX.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| TGTX | 2023-01-20 | 356.9 | 17.8 | -7.5 | -7.7 |
| TGTX | 2023-01-19 | 341.9 | 17.1 | -7.2 | -7.3 |
| TGTX | 2023-01-18 | 344.5 | 17.2 | -7.3 | -7.4 |
| TGTX | 2023-01-17 | 372.5 | 18.6 | -7.8 | -8.0 |
| TGTX | 2023-01-13 | 394.2 | 19.7 | -8.3 | -8.5 |
| TGTX | 2023-01-12 | 381.8 | 19.1 | -8.0 | -8.2 |
TGTX Growth Metrics
- Its 4 year net income to common stockholders growth rate is now at -104.96%.
- The 5 year cash and equivalents growth rate now stands at -44.6%.
- Its 3 year price growth rate is now at -14.55%.
The table below shows TGTX's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 5.025 | -239.209 | -238.679 |
| 2022-06-30 | 6.961 | -271.915 | -288.498 |
| 2022-03-31 | 7.912 | -282.968 | -326.485 |
| 2021-12-31 | 6.689 | -295.634 | -348.101 |
| 2021-09-30 | 4.406 | -260.751 | -342.98 |
| 2021-06-30 | 2.414 | -250.082 | -344.506 |
TGTX's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- TGTX has a Quality Grade of D, ranking ahead of 7.5% of graded US stocks.
- TGTX's asset turnover comes in at 0.005 -- ranking 411th of 681 Pharmaceutical Products stocks.
- TMBR, ATRA, and EVOK are the stocks whose asset turnover ratios are most correlated with TGTX.
The table below shows TGTX's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.005 | 0.881 | -27.668 |
| 2021-03-31 | 0.002 | 0.847 | -42.516 |
| 2020-12-31 | 0.000 | 1.000 | -36.140 |
| 2020-09-30 | 0.001 | 1.000 | -86.159 |
| 2020-06-30 | 0.001 | 1.000 | -22.399 |
| 2020-03-31 | 0.001 | 1.000 | -12.310 |
TGTX Price Target
For more insight on analysts targets of TGTX, see our TGTX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $75.33 | Average Broker Recommendation | 1.44 (Moderate Buy) |
TGTX Stock Price Chart Interactive Chart >
TGTX Price/Volume Stats
| Current price | $14.63 | 52-week high | $14.85 |
| Prev. close | $14.15 | 52-week low | $3.48 |
| Day low | $13.71 | Volume | 4,000,500 |
| Day high | $14.85 | Avg. volume | 5,745,900 |
| 50-day MA | $9.97 | Dividend yield | N/A |
| 200-day MA | $7.10 | Market Cap | 2.13B |
TG Therapeutics, Inc. (TGTX) Company Bio
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company was founded in 1993 and is based in New York, New York.
Latest TGTX News From Around the Web
Below are the latest news stories about TG THERAPEUTICS INC that investors may wish to consider to help them evaluate TGTX as an investment opportunity.
TG Therapeutics' (NASDAQ:TGTX) investors will be pleased with their 26% return over the last five yearsWhen you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore... |
TG Therapeutics (TGTX) Outpaces Stock Market Gains: What You Should KnowTG Therapeutics (TGTX) closed at $13.20 in the latest trading session, marking a +0.61% move from the prior day. |
TG Therapeutics (TGTX) Soars 8.7%: Is Further Upside Left in the Stock?TG Therapeutics (TGTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term. |
TG Therapeutics (TGTX) Upgraded to Buy: What Does It Mean for the Stock?TG Therapeutics (TGTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
TG Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare ConferencePresentation scheduled for Monday, January 9, 2023 at 9:45 AM PTNEW YORK, Jan. 06, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference, being held at the Westin St. Francis, in San Francisco, CA. The presentation is scheduled to take place on Monday, January 9, 2023, at 9:45 AM PT. A live webcast of this presentation will be availa |
TGTX Price Returns
| 1-mo | 40.67% |
| 3-mo | 155.77% |
| 6-mo | 164.08% |
| 1-year | 50.36% |
| 3-year | 0.76% |
| 5-year | 19.43% |
| YTD | 23.67% |
| 2022 | -37.74% |
| 2021 | -63.48% |
| 2020 | 368.65% |
| 2019 | 170.73% |
| 2018 | -50.00% |
Continue Researching TGTX
Want to see what other sources are saying about Tg Therapeutics Inc's financials and stock price? Try the links below:Tg Therapeutics Inc (TGTX) Stock Price | Nasdaq
Tg Therapeutics Inc (TGTX) Stock Quote, History and News - Yahoo Finance
Tg Therapeutics Inc (TGTX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...